Showing results (71-80 of 330) with videos related to
Sort By:
Pageof 33
Statistics in Medicine|January 7, 2000
A transitional model of barrier methods compliance with unbalanced loss to follow-upP L Chen, E Wong, R Dominik, et al.Psychological Science|November 25, 2003
Selective attention determines emotional responses to novel visual stimuliJane E Raymond, Mark J Fenske, Nader T TavassoliAmerican Journal of Botany|February 27, 2001
Estimating near-infrared leaf reflectance from leaf structural characteristicsM R Slaton, E Raymond Hunt, W K SmithClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatinN Zeghari-Squalli, E Raymond, E Cvitkovic, et al.British Journal of Cancer|September 18, 2008
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?C Le Tourneau, S Faivre, M Serova, et al.Trends in Cognitive Sciences|January 13, 2011
The attentional blinkK L Shapiro, J E Raymond, K M ArnellCancer Chemotherapy and Pharmacology|July 21, 1999
Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell linesS Faivre, E Raymond, J M Woynarowski, et al.Brain : a Journal of Neurology|October 1, 1996
Directional defects in pursuit and motion perception in humans with unilateral cerebral lesionsJ J Barton, J A Sharpe, J E RaymondAnnals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
Oxaliplatin: a review of preclinical and clinical studiesE Raymond, S G Chaney, A Taamma, et al.Investigative Ophthalmology & Visual Science|August 1, 1992
Visual accommodation and sustained visual resolution in multiple sclerosisN A Ogden, J E Raymond, T P SelandPageof 33